| RS281860609 |
HBA2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS281860615 |
HBA2
|
Health Risk |
Conflicting classifications of pathogenicity |
HBA2-related disorder, HBA2-related disorder |
| RS281860626 |
HBA2
|
Health Risk |
Likely pathogenic |
— |
| RS281860639 |
KDM5C
|
Health Risk |
Pathogenic |
Syndromic X-linked intellectual disability Claes-Jensen type, Syndromic X-linked intellectual disability Claes-Jensen type |
| RS281860640 |
G6PD
|
Health Risk |
Pathogenic |
Anemia, nonspherocytic hemolytic |
| RS281860663 |
SMPD1
|
Health Risk |
Pathogenic |
Niemann-Pick disease, type A |
| RS281860665 |
SMPD1
|
Health Risk |
Pathogenic |
Niemann-Pick disease, type B |
| RS281860666 |
SMPD1
|
Health Risk |
Likely pathogenic |
Niemann-Pick disease, type B |
| RS281860668 |
SMPD1
|
Health Risk |
Likely pathogenic |
Niemann-Pick disease, type A |
| RS281860669 |
SMPD1
|
Health Risk |
Likely pathogenic |
Niemann-Pick disease, type A |
| RS281860676 |
SMPD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Niemann-Pick disease, type B |
| RS281860677 |
SMPD1
|
Health Risk |
Pathogenic |
Niemann-Pick disease, type A |
| RS281864468 |
AIFM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease X-linked recessive 4, Charcot-Marie-Tooth disease X-linked recessive 4 |
| RS281864497 |
HBB
|
Health Risk |
Pathogenic |
beta Thalassemia, beta Thalassemia |
| RS281864502 |
HBA1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS281864518 |
HBB
|
Health Risk |
Pathogenic/Likely pathogenic |
beta Thalassemia, beta Thalassemia |
| RS281864519 |
HBB
|
Health Risk |
Pathogenic |
beta Thalassemia, beta Thalassemia |
| RS281864520 |
HBB
|
Health Risk |
Pathogenic |
beta Thalassemia, beta Thalassemia |
| RS281864525 |
HBB
|
Health Risk |
Pathogenic |
beta Thalassemia, beta Thalassemia |
| RS281864527 |
HBB
|
Health Risk |
Pathogenic |
beta Thalassemia, beta Thalassemia |
| RS281864528 |
HBB
|
Health Risk |
Pathogenic |
beta Thalassemia, beta Thalassemia |
| RS281864530 |
HBB
|
Health Risk |
Pathogenic |
— |
| RS281864531 |
HBB
|
Health Risk |
Pathogenic |
beta Thalassemia, beta Thalassemia |
| RS281864532 |
HBB
|
Health Risk |
Likely pathogenic |
BETA-PLUS-THALASSEMIA, beta Thalassemia |
| RS281864535 |
HBA1
|
Health Risk |
Pathogenic/Likely pathogenic |
alpha Thalassemia, Heinz body anemia |
| RS281864539 |
HBA2
|
Health Risk |
Pathogenic |
alpha Thalassemia, alpha Thalassemia |
| RS281864544 |
HBB
|
Health Risk |
Pathogenic |
beta Thalassemia, beta Thalassemia |
| RS281864550 |
HBA2
|
Health Risk |
Pathogenic/Likely pathogenic |
alpha Thalassemia, Hemoglobin H disease |
| RS281864560 |
HBA2
|
Health Risk |
Likely pathogenic |
HEMOGLOBIN H HYDROPS FETALIS SYNDROME, HEMOGLOBIN H HYDROPS FETALIS SYNDROME |
| RS281864566 |
HBA1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS281864571 |
HBA1
|
Health Risk |
Likely pathogenic |
Erythrocytosis, familial |
| RS281864581 |
HBB;LOC106099062;LOC107133510
|
Health Risk |
Pathogenic |
Hemoglobinopathy, Hemoglobinopathy |
| RS281864719 |
ALK
|
Health Risk |
Pathogenic |
Neuroblastoma, susceptibility to |
| RS281864720 |
ALK
|
Health Risk |
Pathogenic |
Neuroblastoma, susceptibility to |
| RS281864779 |
PRKAR1A
|
Health Risk |
Pathogenic |
Carney complex, type 1 |
| RS281864780 |
PRKAR1A
|
Health Risk |
Likely pathogenic |
Carney complex, type 1 |
| RS281864782 |
PRKAR1A
|
Health Risk |
Pathogenic |
Carney complex, type 1 |
| RS281864783 |
PRKAR1A
|
Health Risk |
Pathogenic |
Carney complex, type 1 |
| RS281864784 |
PRKAR1A
|
Health Risk |
Pathogenic |
Carney complex, type 1 |
| RS281864785 |
PRKAR1A
|
Health Risk |
Pathogenic |
Carney complex, type 1 |
| RS281864790 |
PRKAR1A
|
Health Risk |
Pathogenic |
Carney complex, type 1 |
| RS281864791 |
PRKAR1A
|
Health Risk |
Pathogenic |
Familial atrial myxoma, Familial atrial myxoma |
| RS281864792 |
PRKAR1A
|
Health Risk |
Pathogenic |
Carney complex, type 1 |
| RS281864797 |
PRKAR1A
|
Health Risk |
Likely pathogenic |
Carney complex, type 1 |
| RS281864798 |
PRKAR1A
|
Health Risk |
Pathogenic |
Carney complex, type 1 |
| RS281864799 |
PRKAR1A
|
Health Risk |
Likely pathogenic |
Carney complex, type 1 |
| RS281864800 |
PRKAR1A
|
Health Risk |
Likely pathogenic |
Carney complex, type 1 |
| RS281864801 |
PRKAR1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Pigmented nodular adrenocortical disease, primary |
| RS281864809 |
HBA2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS281864810 |
HBA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Heinz body anemia, alpha Thalassemia |
| RS281864811 |
HBA2
|
Health Risk |
Conflicting classifications of pathogenicity |
alpha Thalassemia, alpha Thalassemia |
| RS281864817 |
HBA2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS281864819 |
HBA2
|
Health Risk |
Likely pathogenic |
alpha Thalassemia, alpha Thalassemia |
| RS281864821 |
HBA2
|
Health Risk |
Likely pathogenic |
alpha Thalassemia, alpha Thalassemia |
| RS281864823 |
HBA2
|
Health Risk |
Conflicting classifications of pathogenicity |
alpha Thalassemia, alpha Thalassemia |
| RS281864828 |
HBA1
|
Health Risk |
Pathogenic; other |
HEMOGLOBIN KANAGAWA, Erythrocytosis |
| RS281864829 |
HBA2
|
Health Risk |
Pathogenic |
Thalassemia, Thalassemia |
| RS281864834 |
HBA2
|
Health Risk |
Pathogenic/Likely pathogenic |
HEMOGLOBIN L (FERRARA), HEMOGLOBIN SINAI |
| RS281864840 |
HBA2
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS281864844 |
HBA2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS281864846 |
HBA2
|
Health Risk |
Pathogenic |
Non-immune hydrops fetalis, HEMOGLOBIN H HYDROPS FETALIS SYNDROME |
| RS281864849 |
HBA2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS281864853 |
HBA2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS281864858 |
HBA2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS281864863 |
LOC106804612;HBA2
|
Health Risk |
Likely pathogenic |
— |
| RS281864878 |
HBA2
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS281864889 |
HBA2
|
Health Risk |
Pathogenic |
alpha Thalassemia, alpha Thalassemia |
| RS281864895 |
HBA1
|
Health Risk |
Pathogenic |
alpha Thalassemia, alpha Thalassemia |
| RS281864898 |
HBB
|
Health Risk |
Pathogenic |
beta Thalassemia, beta Thalassemia |
| RS281864899 |
HBB
|
Health Risk |
Pathogenic |
beta Thalassemia, beta Thalassemia |
| RS281864901 |
HBB
|
Health Risk |
Pathogenic |
Beta zero thalassemia, beta Thalassemia |
| RS281864906 |
HBB
|
Health Risk |
Pathogenic |
beta Thalassemia, beta Thalassemia |
| RS281864913 |
GLRA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary hyperekplexia, Hyperekplexia 1 |
| RS281864914 |
GLRA1
|
Health Risk |
Likely pathogenic |
Hyperekplexia 1, Hereditary hyperekplexia |
| RS281864915 |
GLRA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hyperekplexia 1, Hereditary hyperekplexia |
| RS281864916 |
GLRA1
|
Health Risk |
Pathogenic |
Hyperekplexia 1, Hereditary hyperekplexia |
| RS281864917 |
GLRA1
|
Health Risk |
Likely pathogenic |
Hyperekplexia 1, Hereditary hyperekplexia |
| RS281864918 |
GLRA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary hyperekplexia, Hyperekplexia 1 |
| RS281864919 |
GLRA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary hyperekplexia, Hereditary hyperekplexia |
| RS281864920 |
GLRA1
|
Health Risk |
Pathogenic |
Hyperekplexia 1, Hyperekplexia 1 |
| RS281864921 |
GLRA1
|
Health Risk |
Pathogenic |
Hyperekplexia 1, Hereditary hyperekplexia |
| RS281864922 |
GLRB
|
Health Risk |
Pathogenic/Likely pathogenic |
Hyperekplexia 2, Hyperekplexia 2 |
| RS281864923 |
SLC6A5
|
Health Risk |
Pathogenic |
Hyperekplexia 3, Hyperekplexia 3 |
| RS281864924 |
SLC6A5
|
Health Risk |
Pathogenic |
Hyperekplexia 3, Hyperekplexia 3 |
| RS281864925 |
SLC6A5
|
Health Risk |
Pathogenic |
Hyperekplexia 3, Hyperekplexia 3 |
| RS281864926 |
SLC6A5
|
Health Risk |
Pathogenic |
Hyperekplexia 3, Hyperekplexia 3 |
| RS281864927 |
TTN
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Tibial muscular dystrophy |
| RS281864928 |
TTN
|
Health Risk |
Pathogenic/Likely pathogenic |
Tibial muscular dystrophy, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS281864929 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Tibial muscular dystrophy, Tibial muscular dystrophy |
| RS281864930 |
TTN
|
Health Risk |
Pathogenic |
Tibial muscular dystrophy, Myopathy |
| RS281864932 |
TTN
|
Health Risk |
Pathogenic |
Tibial muscular dystrophy, Tibial muscular dystrophy |
| RS281864933 |
TTN
|
Health Risk |
Pathogenic |
Tibial muscular dystrophy, Tibial muscular dystrophy |
| RS281864934 |
CHMP2B
|
Health Risk |
Pathogenic |
Frontotemporal dementia and/or amyotrophic lateral sclerosis 7, Frontotemporal dementia and/or amyotrophic lateral sclerosis 7 |
| RS281864936 |
MLH1
|
Health Risk |
Pathogenic |
Lynch syndrome, Hereditary cancer-predisposing syndrome |
| RS281864938 |
MLH1
|
Health Risk |
Pathogenic |
Lynch syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS281864944 |
MSH2
|
Health Risk |
Pathogenic |
Lynch syndrome, Hereditary cancer-predisposing syndrome |
| RS281864947 |
GNPTAB
|
Health Risk |
Likely pathogenic |
Pseudo-Hurler polydystrophy, Mucolipidosis type II |
| RS281864953 |
GNPTAB
|
Health Risk |
Likely pathogenic |
Pseudo-Hurler polydystrophy, Mucolipidosis type II |
| RS281864954 |
GNPTAB
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS281864955 |
GNPTAB
|
Health Risk |
Pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |